Ibrahim Azar
Impact in
-
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
-
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 17
- Lung Cancer Research Studies 4
- Pancreatic and Hepatic Oncology Research 4
-
- Cancer therapeutics and mechanisms 3
- RNA Research and Splicing 2
- Co-authors
- Jacques Archambault (1 shared paper)Thibault Mésplède (1 shared paper)David Gagnon (1 shared paper)Hélène Sénéchal (1 shared paper)François Coutlée (1 shared paper)Syed Mehdi (7 shared papers)Syed J. Mehdi (1 shared paper)Mohammed Najeeb Al Hallak (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Molecular Cancer Therapeutics (1 paper)JAMA Network Open (1 paper)Advances in experimental medicine and biology (1 paper)RNA Biology (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Ibrahim Azar
23 papers receiving 229 citations
Peers
Comparison fields: 5 of 61
- Oncology 135
- Epidemiology 76
- Pulmonary and Respiratory Medicine 45
- Complementary and Manual Therapy 3
- Cancer Research 20
Countries citing papers authored by Ibrahim Azar
This map shows the geographic impact of Ibrahim Azar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Azar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Azar more than expected).
Fields of papers citing papers by Ibrahim Azar
This network shows the impact of papers produced by Ibrahim Azar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Azar. The network helps show where Ibrahim Azar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ibrahim Azar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 71 | |
| 2 | 1999 | 30 | |
| 3 | 2019 | 24 | |
| 4 | 2021 | 22 | |
| 5 | 2022 | 14 | |
| 6 | 2015 | 11 | |
| 7 | 2023 | 11 | |
| 8 | 2021 | 9 | |
| 9 | 2017 | 8 | |
| 10 | 2017 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2020 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2025 | 1 |
About Ibrahim Azar
Ibrahim Azar is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Economics and Econometrics, having authored 24 papers that have together received 236 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Economic and Financial Impacts of Cancer (3 papers), Cancer therapeutics and mechanisms (3 papers), RNA Research and Splicing (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (135 citations), Epidemiology (76 citations), Pulmonary and Respiratory Medicine (45 citations), Complementary and Manual Therapy (3 citations) and Cancer Research (20 citations). Ibrahim Azar has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Jacques Archambault, Thibault Mésplède, David Gagnon, Hélène Sénéchal, François Coutlée, Syed Mehdi, Syed J. Mehdi, Mohammed Najeeb Al Hallak, Misako Nagasaka and Ammar Sukari. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, JAMA Network Open, Advances in experimental medicine and biology and RNA Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.